Chemical Structure (Wynzora 01)
Wynzora Cream
Product Images NDC 73499-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Wynzora (NDC 73499-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mc2 Therapeutics Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Wynzora 02)
Principal Display Panel (60 g Tube Carton)
Wynzora is a cream medication for topical use only, containing calcipotriene and betamethasone dipropionate. It is meant to be applied once a day to affected areas or as directed by a physician. Each gram of cream contains 50 mg of calcipotriene and 0.4 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone). The cream also contains various inactive ingredients. The storage temperature should be kept between 20°C-75°C (68°F-86°F), and the medication should not be frozen. The cream is distributed by EP Health, LLC and manufactured for MC2 Therapeutics in the United States and the United Kingdom. No other information on its use or indications is given.*
Wynzora 04
This is a description of a cream named "AVYAViaV4" which is for topical use only. It contains "calipotriene and betamethasone dipropionate". The cream is manufactured by Epihealth for MC2 Therapeutics. The cream comes in a tube containing 30 milligrams of cliprionssnd and 0.44 milligrams of a certain substance. The NDC number for the drug is 7349900108.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
